Market Cap
$79.53 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$304.61 B |
![]() |
$93.24 B |
Marinomed Biotech AG | $76.72 B |
![]() |
$74.13 B |
![]() |
$68.42 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Regeneron Pharmaceuticals, Inc. is a biotechnology company dedicated to molecules signaling, and targeted antibody drugs. Thanks to its patented treatments and technologies, Regeneron provides remedies for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic diseases, infectious diseases, and rare diseases.
Regeneron Pharmaceuticals, Inc. has the following listings and related stock indices.
Stock: NASDAQ: REGN
Stock: BMV: REGN
Stock: Bovespa: REGN34
Stock: FSX: RGO
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.